ICU Medical Executive and Leadership Team

Dan Woolson, the President at ICU Medical, directs the overarching corporate strategy and operational execution for the entire organization. Overseeing the integration of infusion therapy, airway management, and hemodynamic monitoring business units, the President ensures alignment between manufacturing capabilities and market demand. This leadership role involves driving growth initiatives across North American and international healthcare sectors, focusing on expanding the reach of advanced medical devices. By optimizing operational efficiency and resource allocation, Dan Woolson directly impacts the company's ability to deliver reliable support to hospitals and specialized units like the NICU. Furthermore, the President coordinates with other C-suite leaders to foster a culture of innovation and excellence in patient care. Through strategic planning and market analysis, Woolson secures the company's long-term financial stability and market leadership, ensuring that the organization remains a trusted partner for caregivers and patients seeking high-quality medical solutions.

Ben Sousa, the Chief Information Officer at ICU Medical, directs the digital infrastructure supporting global medical device manufacturing and distribution. Overseeing enterprise-wide data security and systems integration, the Chief Information Officer ensures seamless connectivity between clinical workflows and internal operational platforms. This leadership role involves architecting scalable cloud solutions that facilitate real-time data access for healthcare professionals across diverse hospital settings. By optimizing internal network reliability, Ben Sousa directly impacts the efficiency of infusion therapy systems and hemodynamic monitoring tools. Furthermore, the Chief Information Officer manages the cybersecurity posture to protect sensitive patient information across North American and international markets. Through the implementation of advanced analytics, Sousa drives technological transformation, enabling the company to maintain high standards of safety and reliability in complex medical environments while supporting long-term digital growth strategies.

Robert Armstrong, the Chief Technology Officer & Vice President, Research & Development at ICU Medical, leads the innovation pipeline for next-generation infusion therapy and airway management devices. Overseeing the engineering teams, the Chief Technology Officer & Vice President, Research & Development translates clinical requirements into advanced hardware and software solutions that simplify complex medical workflows. This leadership role involves managing the entire product lifecycle, from initial design concepts to final regulatory approval and market launch. By prioritizing research into hemodynamic monitoring and pain management technologies, Robert Armstrong directly influences the company's competitive position in the global medical device sector. Furthermore, the Chief Technology Officer & Vice President, Research & Development collaborates with clinical experts to ensure all new developments meet the rigorous safety standards required in NICU and PICU environments. Armstrong secures the future of the product portfolio through continuous investment in cutting-edge medical technology.

Jesús Cabrera, the Chief Medical Officer at ICU Medical, directs the clinical strategy and safety protocols governing the company's extensive range of medical devices. Overseeing medical affairs and clinical research, the Chief Medical Officer ensures that infusion therapy systems and airway management tools align with current healthcare standards and patient safety requirements. This leadership role involves providing expert guidance to product development teams, ensuring that every device enhances patient outcomes in hospitals and home care settings. By evaluating clinical data and monitoring real-world performance, Jesús Cabrera directly impacts the efficacy of the company's specialized solutions. Furthermore, the Chief Medical Officer maintains critical relationships with healthcare professionals and regulatory bodies to validate the clinical utility of new innovations. Through rigorous oversight of medical practices, Cabrera supports the company's mission to simplify complex workflows while maintaining the highest levels of patient care and safety across all global markets.